← Open Payments lookup

RALPH ABLASEAU: Open Payments

NPI 1982869715 · WILLIAMSBURG, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,111 in 109 payments from 16 companies in 2025. Trend: 2023 $1,175 · 2024 $4,524 · 2025 $2,111

Food & beverage: $1,996Consulting: $115
CompanyPaymentsAmount
ABBVIE INC.25$428
E.R. Squibb & Sons, L.L.C.9$249
Otsuka America Pharmaceutical, Inc.12$206
Supernus Pharmaceuticals, Inc.13$197
Alkermes, Inc.9$185
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)12$180
Vanda Pharmaceuticals Inc.9$151
Janssen Scientific Affairs, LLC1$115
Janssen Pharmaceuticals, Inc4$87
Teva Pharmaceuticals USA, Inc.5$86

Products named: VRAYLAR, COBENFY, Qelbree, CAPLYTA, SPRAVATO, ARISTADA, FANAPT, REXULTI.

Industry payments across VA — which companies pay providers there.